Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis

NCT05248230 is registered in ClinicalTrials.gov with 4D Molecular Therapeutics as lead sponsor.

NCT NCT05248230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05248230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Phase 1/2 Trial of Gene Therapy 4D-710 in Adults With Cystic Fibrosis
Lead sponsor
4D Molecular Therapeutics
Phase
Phase 2
Overall status
Recruiting
Start date
March 29, 2022
Completion date
June 30, 2031
Enrollment
30 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis lung